Riekkinen_1996_Eur.J.Pharmacol_308_243

Reference

Title : Depletion of serotonin, dopamine and noradrenaline in aged rats decreases the therapeutic effect of nicotine, but not of tetrahydroaminoacridine - Riekkinen_1996_Eur.J.Pharmacol_308_243
Author(s) : Riekkinen M , Aroviita L , Kivipelto M , Taskila K , Riekkinen P, Jr.
Ref : European Journal of Pharmacology , 308 :243 , 1996
Abstract :

The present study investigates the effects of nicotine (0.1 and 0.3 mg/kg) and tetrahydroaminoacridine (3 mg/kg) treatment on spatial navigation in aged control and p-chlorophenylalanine (a serotonin (5-hydroxytryptamine, 5-HT) synthesis inhibitor, 400 mg/kg on 3 successive days, i.p.)-treated rats. p-Chlorophenylalanine did not aggravate the water maze failure of aged rats. Nicotine (0.3 mg/kg) was more effective than tetrahydroaminoacridine (3 mg/kg) in promoting water maze navigation by aged control rats. p-Chlorophenylalanine blocked the therapeutic effect of nicotine (0.3 mg/kg),but did not decrease the effect of tetrahydroaminoacridine (3 mg/kg) in aged rats. Frontal cortex dopamine levels and choline acetyltransferase activity were lower in aged rats, but 5-HT and noradrenaline levels were unaltered. p-Chlorophenylalanine decreased selectively 5-HT levels in young rats, but in aged rats 5-HT, dopamine and noradrenaline levels were decreased. These results suggest that aged rats are neurochemically more sensitive to p-chlorophenylalanine treatment and that tetrahydroaminoacridine may more effectively than nicotine stimulate spatial learning if 5-HT, dopamine and noradrenaline systems are severely affected.

PubMedSearch : Riekkinen_1996_Eur.J.Pharmacol_308_243
PubMedID: 8858294

Related information

Citations formats

Riekkinen M, Aroviita L, Kivipelto M, Taskila K, Riekkinen P, Jr. (1996)
Depletion of serotonin, dopamine and noradrenaline in aged rats decreases the therapeutic effect of nicotine, but not of tetrahydroaminoacridine
European Journal of Pharmacology 308 :243

Riekkinen M, Aroviita L, Kivipelto M, Taskila K, Riekkinen P, Jr. (1996)
European Journal of Pharmacology 308 :243